{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:45:23Z","timestamp":1790783123836,"version":"4.1.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02571","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T04:35:21Z","timestamp":1541392521000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells"],"prefix":"10.3389","volume":"9","author":[{"given":"Alexandre T. J.","family":"Maria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Toupet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Maumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Rozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Catherine","family":"Vozenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Le Quellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","article-title":"Fibrosis\u2013a lethal component of systemic sclerosis","volume":"10","author":"Ho","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5301\/jsrd.5000240","article-title":"The mighty fibroblast and its utility in scleroderma research","volume":"2","author":"Garret","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.autrev.2010.09.015","article-title":"Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy","volume":"10","author":"Wei","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11926-015-0555-7","article-title":"Cellular therapies in systemic sclerosis: recent progress","volume":"18","author":"van","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12016-016-8552-9","article-title":"Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis","volume":"52","author":"Maria","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/art.39477","article-title":"Antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaut.2016.03.013","article-title":"Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis","volume":"70","author":"Maria","year":"2016","journal-title":"J Autoimmun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e14247","DOI":"10.1371\/journal.pone.0014247","article-title":"IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis","volume":"5","author":"Bouffi","year":"2010","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/21678707.2016.1114454","article-title":"Treatment of rapidly progressive systemic sclerosis: current and futures perspectives","volume":"4","author":"Mendoza","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"key":"B14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/bmt.2016.211","article-title":"Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis","volume":"52","author":"Del","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"B15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.49.1.40","article-title":"Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis","volume":"49","author":"Gustafsson","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/rheumatology\/kel285","article-title":"Immunological basis of systemic sclerosis","volume":"45","author":"Zuber","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.jid.5700109","article-title":"IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice","volume":"126","author":"Gallucci","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12483971","article-title":"Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6","volume":"97","author":"Duncan","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0153101","DOI":"10.1371\/journal.pone.0153101","article-title":"Intrinsic deregulation of vascular smooth muscle and myofibroblast differentiation in mesenchymal stromal cells from patients with systemic sclerosis","volume":"11","author":"Hegner","year":"2016","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4636859","DOI":"10.1155\/2016\/4636859","article-title":"Vascular remodelling and mesenchymal transition in systemic sclerosis","volume":"2016","author":"Nicolosi","year":"2016","journal-title":"Stem Cells Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.171.3975.1019","article-title":"Scleroderma and the subcutaneous tissue","volume":"171","author":"Fleischmajer","year":"1971","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrrheum.2016.223","article-title":"Systemic sclerosis in 2016: dermal white adipose tissue implicated in SSc pathogenesis","volume":"13","author":"Varga","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/art.39501","article-title":"The american college of rheumatology provisional composite response index for clinical trials in early diffuse cutaneous systemic sclerosis","volume":"68","author":"Khanna","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1136\/annrheumdis-2015-208024","article-title":"Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis","volume":"75","author":"Dobrota","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T04:35:24Z","timestamp":1541392524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2018.02571"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02571","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]},"article-number":"2571"}}